Preliminary Evaluation of Two Rapid Diagnostic Test Prototypes for Strongyloides Stercoralis Infection — PROTOSS

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Strongyloides Stercoralis Infection Clinical Trial

Official title:
Preliminary Evaluation of Two Rapid Diagnostic Test Prototypes for Strongyloides Stercoralis Infection

Status Not yet recruiting

Clinical Trial Summary

Single center, no profit experimental study on sera available in the Tropica Biobank.

n/a

NCT number	NCT06368609
Study type	Interventional
Source	IRCCS Sacro Cuore Don Calabria di Negrar
Contact	Elvia Malo
Phone	+390456014854
Email	ricerca.clinica@sacrocuore.it
Status	Not yet recruiting
Phase	N/A
Start date	April 2024
Completion date	May 2024

See also
Status	Clinical Trial	Phase
Completed	`NCT04999774` - Evaluation of Strongyloidiasis in Ecuador: a fieLd Laboratory Accuracy Study
Enrolling by invitation	`NCT04056325` - Efficacy, Safety, and PK of Ascending Dosages of Moxidectin Versus Ivermectin Against Strongyloides Stercoralis	Phase 2
Terminated	`NCT03605758` - Treatment of Strongyloides Infection	Phase 3
Not yet recruiting	`NCT06373835` - Efficacy and Safety of Emodepside in Adults Infected With Strongyloidiasis Stercoralis	Phase 2
Completed	`NCT06308705` - The SsRI/NIE Recombinant Antigen ELISA for the Follow up of Patients Infected by Strongyloides Stercoralis	N/A
Completed	`NCT04848688` - Efficacy and Safety of Moxidectin Versus Ivermectin Against Strongyloides Stercoralis	Phase 3
Recruiting	`NCT01308268` - Management of Soil-transmitted Helminthiasis and Strongyloidiasis	N/A